Medical Marijuana Inc (MJNA)
0.0024
0.00 (0.00%)
USD |
OTCM |
Apr 18, 15:53
Medical Marijuana Enterprise Value: 10.85M for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 17, 2024 | 10.85M |
April 16, 2024 | 11.54M |
April 15, 2024 | 11.54M |
April 12, 2024 | 12.57M |
April 11, 2024 | 11.54M |
April 10, 2024 | 12.92M |
April 09, 2024 | 13.95M |
April 08, 2024 | 14.29M |
April 05, 2024 | 14.64M |
April 04, 2024 | 12.57M |
April 03, 2024 | 12.57M |
April 02, 2024 | 12.57M |
April 01, 2024 | 11.88M |
March 28, 2024 | 11.54M |
March 27, 2024 | 12.30M |
March 26, 2024 | 11.88M |
March 25, 2024 | 10.50M |
March 22, 2024 | 10.16M |
March 21, 2024 | 8.782M |
March 20, 2024 | 10.50M |
March 19, 2024 | 10.50M |
March 18, 2024 | 11.54M |
March 15, 2024 | 7.404M |
March 14, 2024 | 7.404M |
March 13, 2024 | 6.371M |
Date | Value |
---|---|
March 12, 2024 | 9.126M |
March 11, 2024 | 10.16M |
March 08, 2024 | 10.16M |
March 07, 2024 | 11.19M |
March 06, 2024 | 11.19M |
March 05, 2024 | 11.19M |
March 04, 2024 | 11.19M |
March 01, 2024 | 11.88M |
February 29, 2024 | 11.54M |
February 28, 2024 | 11.54M |
February 27, 2024 | 11.88M |
February 26, 2024 | 11.88M |
February 23, 2024 | 11.19M |
February 22, 2024 | 12.23M |
February 21, 2024 | 12.92M |
February 20, 2024 | 13.60M |
February 16, 2024 | 14.29M |
February 15, 2024 | 14.64M |
February 14, 2024 | 13.95M |
February 13, 2024 | 14.29M |
February 12, 2024 | 14.64M |
February 09, 2024 | 14.29M |
February 08, 2024 | 14.64M |
February 07, 2024 | 14.64M |
February 06, 2024 | 14.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.371M
Minimum
Mar 13 2024
591.24M
Maximum
Feb 10 2021
77.62M
Average
61.50M
Median
Nov 18 2020
Enterprise Value Benchmarks
Skye Bioscience Inc | 482.99M |
NovaBay Pharmaceuticals Inc | 2.452M |
Palatin Technologies Inc | 21.17M |
iBio Inc | 16.45M |
Theriva Biologics Inc | -12.76M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.8491M |
Revenue (Quarterly) | 4.776M |
Total Expenses (Quarterly) | 4.693M |
Gross Profit Margin (Quarterly) | 79.95% |
Profit Margin (Quarterly) | -17.78% |
Earnings Yield | -3.97K% |